No abstract available
MeSH terms
-
Adenocarcinoma / diagnosis
-
Adenocarcinoma / genetics*
-
Adenocarcinoma / therapy*
-
Adenocarcinoma of Lung
-
Aged
-
Biopsy, Needle
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Follow-Up Studies
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Immunohistochemistry
-
Indoles / therapeutic use*
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / genetics*
-
Lung Neoplasms / therapy*
-
Male
-
Multimodal Imaging / methods
-
Mutation*
-
Neoplasm Invasiveness / pathology
-
Neoplasm Staging
-
Pneumonectomy / methods
-
Polymerase Chain Reaction
-
Positron-Emission Tomography
-
Proto-Oncogene Proteins B-raf / genetics*
-
Radiotherapy, Adjuvant
-
Risk Assessment
-
Sulfonamides / therapeutic use*
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Vemurafenib
Substances
-
Indoles
-
Sulfonamides
-
Vemurafenib
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf